Kolexia
Burban-Provost Patricia Oncologie radiothérapie
Burban-Provost Patricia
Oncologie radiothérapie
Gie Groupement D'imagerie Armoricaine
Plérin, France
19 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Adénocarcinome Carcinome épidermoïde de la tête et du cou Tumeurs du sein Tumeurs épidermoïdes Tumeurs de la tête et du cou Récidive tumorale locale {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Leble Sylvie
Leble Sylvie
Centre Hospitalier de Saint Brieuc, Saint-Brieuc, France
Peiffert Didier
Peiffert Didier
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Choplin Maud
Choplin Maud
Centre Hospitalier de Saint Brieuc, Saint-Brieuc, France
Supiot Stephane
Supiot Stephane
Institut de cancérologie de l'Ouest, Saint-Herblain, France

Industries

Voir plus
AstraZeneca
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
The Lancet. Oncology   16 octobre 2019
Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for metastatic free survival (MFS) after radical prostatectomy (RP): Update at 9 years of the GETUG-AFU 16 phase III randomized trial (NCT00423475).
2019 ASCO Annual Meeting I   26 mai 2019
Pregnancies after breast cancer: Is there a real need for fertility preservation? Results from the ARTEMIS cohort of 60 young patients
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer: Phase III Randomized Study of Adjuvant Radiotherapy With Versus Without Concurrent Goserelin in Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
Essai Clinique (AstraZeneca)   14 mai 2018
Reirradiation and Erbitux in the HNSCC: A Phase II Study, Multicenter, to Evaluate the Efficacy and Safety of the Combination of Reirradiation - Erbitux in Subjects Previously Irradiated and With a Local Recurrent Inoperable Squamous Cell Cancer of the Head and Neck
Essai Clinique (Groupe d'Oncologie Radiothérapie Tête Et Cou)   25 octobre 2017
{{person.lastact6.name}}
{{person.lastact6.jour}}   {{person.lastact6.date}}
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}